EUCTR2011-002022-41-ES进行中（未招募）不适用
Assessment of Therapeutic Response to Benznidazole in patients with Chronic Chagas Disease by Measuring Plasma Parasite Load and the Specific Immune Response against Trypanosoma cruzi. A Randomized, open label, Pilot Clinical Trial
Fundación para la Investigación Biomédica del Hospital Ramón y Cajal0 个研究点开始时间: 2011年7月12日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •?Participant willing and able to give informed consent for participation in the study
- •?Ability to understand study procedures and to comply with them for the entire length of the study
- •?Men and women, more than 20 and less than 50 years old with asymptomatic chronic Chagas disease
- •?No urgent need for benznidazole therapy
- •?Detectable T. cruzi in blood (positive qualitative PCR)
- •?For women of childbearing age an effective contraceptive method must be used during the treatment period and in the month following treatment
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •?Symptomatic acute or chronic Chagas disease
- •?Current pregnancy
- •?Previous therapy with benznidazole, nifurtimox or any other tripanocidal drug
- •?Severe hepatic or renal impairment
- •?Inability to give written informed consent
研究者
相似试验
进行中（未招募）
不适用
Study of the variabiliy in dose-concentration correlation of Benznidazol in adult patients with Chronic Chagas Disease and the relationship between drug pharmacokinetics and adverse reactions.The study will be held in 50 patients with Chronic Chagas Disease.MedDRA version: 14.1Level: LLTClassification code 10008384Term: Chagas' diseaseSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-002900-34-ESCRESIB- International Research Center in Health of Barcelona
进行中（未招募）
1 期
Phase II trial for assessing different benznidazol regimens in the treatment of Chagas disease in adult patients on chronic phase . BERINECE projectEUCTR2016-003789-21-ESFundación Hospital Universitari Vall d'Hebron - Institut de Recerca240
已完成
2 期
The role of metronidazole in COVID-19COVID-19.COVID-19U07.1IRCT20200608047686N1Shahid Beheshti University of Medical Sciences30
已完成
不适用
A pilot study for the efficacy of the non-benzodiazepine hypnotic or orexin receptor antagonist on insomnia in major depressive patients unresponsive to benzodiazepine hypnotic treatment: a randomized open-label trial.major depressive disorderJPRN-UMIN000031032Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital40
尚未招募
不适用
To assess the effect of different topical pharyngeal anaesthetics on total propofol consumption in patients undergoing Endoscopic Retrograde Cholangio Pancreatography(ERCP)CTRI/2021/03/032419M S Ramaiah Medical College